Filing Details
- Accession Number:
- 0001415889-24-020249
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-29 16:30:09
- Reporting Period:
- 2024-07-25
- Accepted Time:
- 2024-07-29 16:30:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-07-25 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-07-25 | 130 | $333.93 | 3,600 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-25 | 589 | $335.85 | 3,011 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-25 | 776 | $336.72 | 2,235 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-25 | 214 | $337.79 | 2,021 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-25 | 5 | $339.22 | 2,016 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-25 | 297 | $339.80 | 1,719 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-25 | 531 | $340.39 | 1,188 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-25 | 724 | $341.60 | 464 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-25 | 244 | $342.53 | 220 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-25 | 90 | $343.79 | 130 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-07-26 | 3,600 | $129.49 | 3,730 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-07-26 | 812 | $336.95 | 2,918 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-26 | 723 | $337.91 | 2,195 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-26 | 1,115 | $339.29 | 1,080 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-07-26 | 950 | $339.78 | 130 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2024-07-25 | 3,600 | $0.00 | 3,600 | $129.49 |
Common Stock | Stock Options | Disposition | 2024-07-26 | 3,600 | $0.00 | 3,600 | $129.49 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
75,869 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
72,269 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 166 | Indirect | By Spouse |
Common Stock | 245,909 | Indirect | By Trust |
Common Stock | 1,742 | Indirect | By Trust |
Common Stock | 28,170 | Indirect | By Trust |
Common Stock | 324,518 | Indirect | By Trust |
Common Stock | 45,596 | Indirect | By Trust |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
- This transaction was executed in multiple trades at prices ranging from $333.73 to $334.015. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $335.36 to $336.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $336.375 to $337.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $337.475 to $338.075. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $338.63 to $339.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $339.66 to $340.065. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $340.15 to $340.825. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $341.22 to $342.095. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $342.32 to $343.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $343.435 to $343.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $336.37 to $337.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $337.38 to $338.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $338.57 to $339.565. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $339.57 to $340.135. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- Shares held in family trusts as to which the Reporting Person is sole trustee and members of the Reporting Person's immediate family are beneficiaries.
- Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
- Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
- Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.